347 related articles for article (PubMed ID: 35693928)
1. Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years.
Ehata S; Miyazono K
Front Cell Dev Biol; 2022; 10():883523. PubMed ID: 35693928
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
3. Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?
Ehata S; Yokoyama Y; Takahashi K; Miyazono K
Pathol Int; 2013 Jun; 63(6):287-96. PubMed ID: 23782330
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β and bone morphogenetic protein actions in brain tumors.
Caja L; Bellomo C; Moustakas A
FEBS Lett; 2015 Jun; 589(14):1588-97. PubMed ID: 25957771
[TBL] [Abstract][Full Text] [Related]
5. Duality of bone morphogenetic proteins in cancer: A comprehensive analysis.
Sharma T; Kapoor A; Mandal CC
J Cell Physiol; 2022 Aug; 237(8):3127-3163. PubMed ID: 35644005
[TBL] [Abstract][Full Text] [Related]
6. Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors.
Chang HM; Qiao J; Leung PC
Hum Reprod Update; 2016 Dec; 23(1):1-18. PubMed ID: 27797914
[TBL] [Abstract][Full Text] [Related]
7. BMP signaling components are expressed in human fracture callus.
Kloen P; Di Paola M; Borens O; Richmond J; Perino G; Helfet DL; Goumans MJ
Bone; 2003 Sep; 33(3):362-71. PubMed ID: 13678778
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction by bone morphogenetic proteins.
Kawabata M; Imamura T; Miyazono K
Cytokine Growth Factor Rev; 1998 Mar; 9(1):49-61. PubMed ID: 9720756
[TBL] [Abstract][Full Text] [Related]
9. The Dual Role of Bone Morphogenetic Proteins in Cancer.
Bach DH; Park HJ; Lee SK
Mol Ther Oncolytics; 2018 Mar; 8():1-13. PubMed ID: 29234727
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL).
Dzietczenia J; Wróbel T; Jaźwiec B; Mazur G; Butrym A; Poręba R; Kuliczkowski K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e217-21. PubMed ID: 20491995
[TBL] [Abstract][Full Text] [Related]
11. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
[TBL] [Abstract][Full Text] [Related]
12. TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.
Pickup MW; Owens P; Moses HL
Cold Spring Harb Perspect Biol; 2017 May; 9(5):. PubMed ID: 28062564
[TBL] [Abstract][Full Text] [Related]
13. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
14. Mechanism for the action of bone morphogenetic proteins and regulation of their activity.
Ebara S; Nakayama K
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S10-5. PubMed ID: 12205413
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins and cancer: review of the literature.
Thawani JP; Wang AC; Than KD; Lin CY; La Marca F; Park P
Neurosurgery; 2010 Feb; 66(2):233-46; discussion 246. PubMed ID: 20042986
[TBL] [Abstract][Full Text] [Related]
16. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
Lee CW; Ito K; Ito Y
Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
Jiramongkolchai P; Owens P; Hong CC
Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
Nickel J; Dreyer MK; Kirsch T; Sebald W
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
[TBL] [Abstract][Full Text] [Related]
20. Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development.
Holtzhausen A; Golzio C; How T; Lee YH; Schiemann WP; Katsanis N; Blobe GC
FASEB J; 2014 Mar; 28(3):1248-67. PubMed ID: 24308972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
